1-2 of 2
Guy R. Simpson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer

Nicola E. Annels, David Mansfield, Mehreen Arif, Carmen Ballesteros-Merino, Guy R. Simpson, Mick Denyer, Sarbjinder S. Sandhu, Alan A. Melcher, Kevin J. Harrington, Bronwyn Davies, Gough Au, Mark Grose, Izhar Bagwan, Bernard Fox, Richard Vile, Hugh Mostafid, Darren Shafren, Hardev S. Pandha
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (19): 5818–5831.
https://doi.org/10.1158/1078-0432.CCR-18-4022
Published: 01 October 2019
View article titled, Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer
Open the PDF for Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer in another window
Includes: Supplementary data
Journal Articles

Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma

Hardev S. Pandha, Lucy Heinemann, Guy R. Simpson, Alan Melcher, Robin Prestwich, Fiona Errington, Matt Coffey, Kevin J. Harrington, Richard Morgan
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (19): 6158–6166.
https://doi.org/10.1158/1078-0432.CCR-09-0796
Published: 30 September 2009
View article titled, Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma
Open the PDF for Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma in another window